Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2021 17 2
Ad26.COV2.S Emergency use authorization Experimental Vaccine Mar/11/2021 6 0
Mesenchymal stem cells Potential treatment - clinical evidence Experimental Other treatment Mar/05/2021 10 0
aRBD-2-7 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021 1 0
aRBD-2-5 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021 1 0
2-((3,5-dichlorophenyl)amino)-5-hydroxyquinazolin-4 (3H)-one Potential treatment - pre-clinical evidence Experimental Antiviral Mar/02/2021 1 0
7-chloro-2-((3,5-dichlorophenyl)amino)quinazolin-4(3H)-one Potential treatment - pre-clinical evidence Experimental Antiviral Mar/02/2021 1 0
mAb 2-15 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/25/2021 1 1